Pharmaceuticals

Enterprenuers

Judge rejects AstraZeneca’s challenge to Medicare drug price negotiations

[ad_1] Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services…

Read More »
Business

CVS and Walgreens to start selling abortion pill mifepristone this month 

[ad_1] A container holding boxes of mifepristone, the first medication in a medical abortion, are prepared for patients at Alamo…

Read More »
Stock Market

The stock market is telling you loud and clear: Now is not the time to fight the Fed or stand up to the bears.

[ad_1] The S&P 500 Index SPX, -1.85% hit resistance this week when an oversold rally failed near the 4080 level.…

Read More »
USA

Maker of preterm birth drug Makena to withdraw it from market | CNN

[ad_1] CNN  —  The maker of the drug Makena, which was approved more than a decade ago to reduce the…

Read More »
Stock Market

BridgeBio Stock Surges on Dwarfism Drug Data. It’s Bad News for BioMarin.

[ad_1] BridgeBio Pharma stock was soaring after the biopharmaceutical company reported positive results in a Phase two clinical trial for…

Read More »
USA

Bempedoic acid improved heart health in patients who can’t tolerate statins, study finds | CNN

[ad_1] CNN  —  Bempedoic acid may be an alternative for people who need to lower their cholesterol but can’t or…

Read More »
Stock Market

Kala Pharmaceuticals Stock Showing Rising Market Leadership; Earns 83 RS Rating

[ad_1] Kala Pharmaceuticals (KALA) stock had its Relative Strength (RS) Rating upgraded from 67 to 83 Friday. When you’re researching…

Read More »
Stock Market

Novavax stock shedding a quarter of its value as vaccine maker’s business in ‘substantial doubt’

[ad_1] Novavax Inc. shares shares sank in the extended session Tuesday after the biotech drug maker posted more than double…

Read More »
Stock Market

The 20 worst U.S. stocks in February: the biggest loser dropped 35%

[ad_1] Updated with month-end prices. The euphoria of January reversed in February, with broad declines for stocks across the board…

Read More »
Stock Market

Novavax: ‘Substantial Doubt’ Around Ability to Continue

[ad_1] Covid-19 vaccine manufacturer Novavax said Tuesday that there is “substantial doubt” about its ability to continue operating through this…

Read More »
Back to top button
Close